
181.69 Delayed Data As of 4:00pm ET | ![]() Today’s Change | 155.02 Today|||52-Week Range 364.31 | -44.10% Year-to-Date |
Is Abiomed a Bad-News Buy Right Now? Dec 04 / MotleyFool.com - Paid Partner Content |
Previous close | 189.22 |
Today’s open | 189.30 |
Day’s range | 179.54 - 189.83 |
Volume | 764,077 |
Average volume (3 months) | 726,253 |
Market cap | $8.6B |
Earnings growth (last year) | +127.01% |
Earnings growth (this year) | -19.93% |
Earnings growth (next 5 years) | +23.00% |
Revenue growth (last year) | +29.59% |
P/E ratio | 37.9 |
Price/Sales | 17.13 |
Price/Book | 9.15 |
Today’s change | Today’s % change | |
---|---|---|
WSTWest Pharmaceutical ... | -2.74 | -1.86% |
HAEHaemonetics Corp | -3.76 | -3.10% |
PENPenumbra Inc | -6.60 | -3.93% |
PODDInsulet Corp | -3.30 | -1.79% |
Next reporting date | January 30, 2020 |
EPS forecast (this quarter) | $1.09 |
Annual revenue (last year) | $769.4M |
Annual profit (last year) | $259.0M |
Net profit margin | 33.66% |
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Danvers, Massachusetts |